Power Corp of Canada’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-174,201
Closed -$5.02M 123
2023
Q4
$5.02M Buy
174,201
+38,243
+28% +$1.16M 0.52% 67
2023
Q3
$4.51M Hold
135,958
0.29% 67
2023
Q2
$4.99M Hold
135,958
0.49% 60
2023
Q1
$5.49M Buy
135,958
+125,349
+1,182% +$5.41M 0.56% 53
2022
Q4
$544K Hold
10,609
0.1% 102
2022
Q3
$464K Buy
+10,609
New +$516K 0.11% 109
2022
Q2
Sell
-1,472
Closed -$76K 161
2022
Q1
$76K Buy
+1,472
New +$76.4K 0.01% 135

Other funds holding PFE

Power Corp of Canada's PFE Position: Q1 2024 in Review

Power Corp of Canada sold out of Pfizer (PFE) in Q1 2024, closing a stake of 174,201 shares — an estimated $5.02M sold.

Power Corp of Canada first reported a position in PFE in Q1 2022 and held it in 7 quarters. The position peaked at $5.49M in Q1 2023. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Power Corp of Canada reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Power Corp of Canada sold 174,201 Pfizer shares in Q1 2024, an estimated $5.02M.
  • Power Corp of Canada first reported a position in Pfizer in Q1 2022 and held it in 7 quarters.
  • Power Corp of Canada's Pfizer position peaked at $5.49M in Q1 2023.
  • 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Power Corp of Canada's 13F filing for Q1 2024, filed 14 May 2024.